BACKGROUND: To evaluate the expression pattern and prognostic significance of the type 1 growth factor receptor (T1GFR) family in colon carcinoma. METHODS: Tissue microarrays were constructed using 127 tumor samples and 47 metastatic lymph nodes and T1GFR family expression was determined by immunohistochemistry. Univariate and multivariate analyses examined clinicopathologic variables for prognostic significance, and the correlation between primary and lymph node expression was determined by Spearman correlation. RESULTS: Overexpression of HER-1, HER-2, HER-3, and HER-4 in tumor samples was 32%, 1%, 12%, and 37%, respectively, and 30%, 0%, 11%, and 24% in nodal samples, respectively. On multivariate analysis, positive margins, lymphatic invasion, and HER-3 expression were significant predictors of survival outcome. There was significant correlation between tumor and regional lymph node expression for the T1GFR family members. Tumor HER-3 expression was associated with lymphatic invasion and distant recurrence. CONCLUSIONS: Tumor HER-3 expression has prognostic utility in individuals with colon carcinoma. Correlation between tumor and lymph node expression of T1GFR family members suggests that tumor receptor status may guide targeted therapy selection.
BACKGROUND: To evaluate the expression pattern and prognostic significance of the type 1 growth factor receptor (T1GFR) family in colon carcinoma. METHODS: Tissue microarrays were constructed using 127 tumor samples and 47 metastatic lymph nodes and T1GFR family expression was determined by immunohistochemistry. Univariate and multivariate analyses examined clinicopathologic variables for prognostic significance, and the correlation between primary and lymph node expression was determined by Spearman correlation. RESULTS: Overexpression of HER-1, HER-2, HER-3, and HER-4 in tumor samples was 32%, 1%, 12%, and 37%, respectively, and 30%, 0%, 11%, and 24% in nodal samples, respectively. On multivariate analysis, positive margins, lymphatic invasion, and HER-3 expression were significant predictors of survival outcome. There was significant correlation between tumor and regional lymph node expression for the T1GFR family members. TumorHER-3 expression was associated with lymphatic invasion and distant recurrence. CONCLUSIONS:TumorHER-3 expression has prognostic utility in individuals with colon carcinoma. Correlation between tumor and lymph node expression of T1GFR family members suggests that tumor receptor status may guide targeted therapy selection.
Authors: Valda C Hilliard; Mark R Frey; Peter J Dempsey; Richard M Peek; D Brent Polk Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-05-26 Impact factor: 4.052
Authors: Christopher S Williams; Jessica K Bernard; Michelle Demory Beckler; Dana Almohazey; Mary Kay Washington; Jesse J Smith; Mark R Frey Journal: Carcinogenesis Date: 2015-04-27 Impact factor: 4.944
Authors: Said Abdullah Khelwatty; Sharadah Essapen; Izhar Bagwan; Margaret Green; Alan Michael Seddon; Helmout Modjtahedi Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240
Authors: Anna H Larsson; Sophie Lehn; Sakarias Wangefjord; Emelie Karnevi; Eugenia Kuteeva; Magnus Sundström; Björn Nodin; Mathias Uhlén; Jakob Eberhard; Helgi Birgisson; Karin Jirström Journal: J Transl Med Date: 2016-05-10 Impact factor: 5.531